Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1829802 · no price history on file
Price series unavailable — No prices available for FTH in [1900-01-01, 2026-07-31]. This symbol may require bring-your-own-key (BYOK) data.
| Days to cover3.8d |
Short interest is FINRA semi-monthly, settlement 2026-07-15.
FTH is not in the screener universe.
No return windows available for FTH.
No risk analytics available for FTH.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Vivo Capital, LLC | 722,020 | $23M | — | new |
| Cormorant Asset Management, LP | 306,222 | $10M | — | new |
| STEMPOINT CAPITAL LP | 265,746 | $8M | — | new |
| MILLENNIUM MANAGEMENT LLC | 146,565 | $5M | — | new |
| FRANKLIN RESOURCES INC | 133,506 | $4M | — | new |
| Caligan Partners LP | 126,002 | $4M | — | new |
| Trails Edge Capital Partners, LP | 125,000 | $4M | — | new |
| MARSHALL WACE, LLP | 65,730 | $2M | — | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. % of shares outstanding not shown: no SEC cover-page share count falls within 120 days of the 2026-Q1 quarter end, so any percentage would rest on a count that cannot speak for this quarter. Holder share counts are shown as filed.
No reported quarters on file for FTH.
